Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Repligen Stock Soared 107% in 2020

TheMotleyFool

0 0

Shares in bioprocessing technology company Repligen (NASDAQ: RGEN) rose by a whopping 107% in 2020, according to data provided by S&P Global Market Intelligence.

Bioprocessing uses biological catalysts to produce a pharmaceutical, chemical, or food in a controlled environment. The key end market is biological drugs, including vaccines, gene therapies, and monoclonal antibodies.

Image source: Getty Images.

Source Fool.com

Like: 0

DHR

Share